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Gene expressionThis study pertains to the regulatory network of neurogenin3 (NGN3, approved symbol: NEUROG3), the main
regulator of insulin producing cells’ formation.
In silico regulatory region analyses of known and novel targets of NGN3 revealed the presence of two variants
of a regulatory module that appeared conserved at the most phylogenetically distant species with pancreas.
Both variants of this module contained binding sites of six transcription factors implicated in pancreas devel-
opment. Nevertheless, an additional factor was found only into the module of the down-regulated by NGN3
genes. Whole genome analyses conﬁrmed the statistical signiﬁcance of these regulatory modules. Investiga-
tion of protein–protein interactions among the factors bound into these sequences indicated the formation of
alternative protein complexes resulting into the up- or down-regulation of the respective genes.
Subsequently, an NGN3-guided regulatory network, was modeled, describing the interactions among the
analyzed genes with their transcriptional regulators, leading into the differentiation of cells capable of pro-
ducing insulin.
© 2012 Elsevier Inc. All rights reserved.1. Introduction
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through gradual determination of developmental potential, until the
fully differentiated cells get committed to their terminal fate. Cellular
identity is deﬁned by the expression of cell or tissue speciﬁc genes.
Therefore differentiation occurs by the exposition of the progenitor
cells into extracellular signaling molecules that output instructions on
the regulation of gene expression through complex regulatory pathways.
In mammals, endodermal progenitor cells give birth to both exo-
crine and endocrine cells of pancreas. The endocrine cells are organized
into the islets of Langerhans and are classiﬁed, according to the hor-
mone that they produce, intoα, β, δ, ε and pancreatic polypeptide cells.
In an effort to develop cell-based therapies, experimental proto-
cols are intended for differentiating embryonic stem cells (ESCs)
into speciﬁc cell types. One of the foremost challenges of the cell ther-
apy of diabetic individuals is to achieve the directed differentiation of
cells capable of producing insulin. Towards the differentiation of ESC
into β cells, as previous studies have already denoted, the NGN3 ex-
pression is crucial for the speciﬁcation of the precursor cells that
will be committed to become insulin producing cells [1]. This
(NGN3) transcription factor induces its’ direct targets leading into
the subsequent differential expression of additional transcription fac-
tors, which guide the differentiation of the β cells [1]. These factors
interplay in various combinations simultaneously or not and ﬁnally
the expression of the insulin gene is achieved [1].
In a reference study the NGN3 gene was selectively induced into
endocrine pancreas progenitors differentiated from murine ESCs [1].
Table 1
The up and down-regulated genes after NGN3 induction that were analyzed and their
biological roles.
Gene Up-regulation
(+)
Down-regulation
(−)
Biological process
IA1 (INSM1) (INSulinoMa
associated 1)
+ Transcription factor
NEUROD1 (NEUROgenic
Differentiation 1)
+ Transcription factor
NKX2-2 (ΝΚ2 family
of homeoproteins)
+ Transcription factor
PAX4 (PAired boX gene 4) + Transcription factor
CDC42 (Cell Division Cycle
42 homolog)
+ Integrin-mediated signaling
pathway
PARD3 (Par-3 PARtitioning
Defective3 homolog C. elegans)
+ Integrin-mediated signaling
pathway
FGD4 (FYVE, RhoGEF and PH
Domain containing 4)
+ Small GTP binding protein
and regulator
RGS4 (Regulator of
G-protein Signaling 4)
+ Small GTP binding protein
and regulator
DCX (DoubleCortin) + Cytoskeletal/ membrane
changes
HUD (ELAVL4) (Hu antigen D)
(Embryonic Lethal, Abnormal
Vision, Drosophila- Like 4)
+ RNA binding processing
ALDH1B1 (ΑLdehyde
DeHydrogenase
1 family, member B1)
+ Metabolic process
WISP1 (WNT1 Inducible
Signaling Pathway protein 1)
− Growth factor and receptor
CTGF (Connective Tissue
Growth Factor)
− Integrin-mediated signaling
pathway
BHLHB2 (BHLHE40) (Βasic
Helix–Loop–Helix domain
containing, class B, 2)
(Basic Helix–Loop–Helix
family, member E40)
− Metabolic process
FZD2 (FriZzleD homolog
2 Drosophila)
− Wnt signaling pathway
PARD6B (Par-6 PARtitioning
Defective 6 homolog C. elegans)
− Integrin-mediated signaling
pathway
VCL (VinCuLin) − Integrin-mediated signaling
pathway
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cells revealed that, after NGN3 induction, some known targets of
this factor along with other genes, that were considered to be puta-
tive NGN3 targets, altered their expression [1].
Genes selected from these microarray data were set at the focal
point of extended in silico analyses [2], in order to identify the binding
sites of NGN3 and further unravel the regulatory network that this
factor coordinates.
More precisely, the regulatory regions of genes, possibly regulated by
NGN3 [2], were set for Transcription Factor Binding Sites (TFBS) predic-
tion. Taking into account the fact that evolutionarily conserved sequences
stand for experimentally identiﬁed regulatory elements, comparative ge-
nomics was applied in order to identify functionally important regions
that represent TFBS. Subsequently, regulatory analyses were performed
on the orthologs of the genes, considered as potential targets of NGN3,
in several species including the most phylogenetically distant ones (ﬁsh-
es), which have pancreas [2].
The application of the abovementioned approach [2] has already led
to the identiﬁcation of a highly conserved regulatory region, in the
orthologs of genes co-regulated by NGN3 and in those WNT5 paralogs
implicated in pancreas development [2,3]. This region, for nowon called
“module”, was consisted of binding sites of six transcription factors
(TFs) with established involvement in pancreas development, further
including additional binding sites for the factor AP4 (TFAP4) (Activating
enhancer-binding Protein 4 (Transcription Factor AP4)) only in the
orthologs of the down-regulated by NGN3 genes WISP1 (WNT-Induced
Secreted Protein 1) and CTGF (Connective Tissue Growth Factor) [2].
Given the consistency of this regulatory module discovery, which
was not identiﬁed in the negative control genes [3], the presented
study looked for it in the same set of orthologs of several other up-
or down-regulated genes upon NGN3 induction, that are presumable
targets of NGN3.
In order to clarify the importance of the presence of AP4 in themod-
ule and the statistical signiﬁcance of the identiﬁcation of the two alter-
native modules, the whole mouse genome was searched for TFBS for
these seven factors. Thereafter, clusters of these binding sites containing
the central regulatory factor (NGN3) were sought. In the sequel, statis-
tical analysis was performed on the results of the regulatory region
analyses of the entiremouse genome. Additionally, the occasional iden-
tiﬁcation of the regulatory modules in the sequences of the genes,
which altered their expression upon NGN3 induction, was investigated
by comparing the upcoming whole genome analyses results with those
of the selected from microarray data genes.
Furthermore, the protein–protein interactions among the
transcription factors of the regulatory modules were studied.
Eventually, the genomic (cis–cis), proteomic (trans–trans) and
combinations of both (cis–trans) interactions among the molecular
players of β-cells’ speciﬁcation were incorporated into a regulatory
network that describes how through the transcriptional regulation
of the analyzed genes, mainly guided by ΝGN3, the generation of
cells capable of producing insulin takes place.
2. Results
2.1. Regulatory region analyses of selected from microarray data genes
Taking into account the data from the aforementioned microarray
experiments [1], genes that appeared to be up or down-regulated
upon NGN3 induction, were selected for regulatory region analyses.
The analyses included the orthologs of the genes only for those species
covering the evolutionary distance from mammals to ﬁshes. These ge-
nomic sequences were submitted for TFBS prediction (Data and
methods) with the intension to verify the already attested binding
sites of NGN3, for the genes that have been proved to be NGN3 regulat-
ed, and further unravel the respective ones in the genes supposed to be
regulated by this factor. Namely, among these genes, IA1, NEUROD1,NKX2-2 and PAX4 are known targets of NGN3 with previously docu-
mented [4] binding motifs of this factor inside their regulatory se-
quences, which our in silico approach managed to corroborate.
Strikingly, the experimentally identiﬁed binding motifs of NGN3 as
well as their relative positions in the sequences of IA1, NEUROD1,
NKX2-2 and PAX4 were conﬁrmed (Supplementary Material 1, Fig.
S1). Moreover, applying a ﬁltering procedure, extensively described in
[2], binding motifs of additional TFs were predicted close to those of
NGN3 in all the analyzed orthologs of these genes, constituting an evo-
lutionary conserved cluster of TFBS. Supplementary Material 2 Fig. S2,
indicatively depicts the conservation of this TFBS assemblage in the
orthologs ofNEUROD1. The computational regulatory element discovery
through this approach had also led to the identiﬁcation of the same
group of TFBS in the orthologs of the genes WISP1 and CTGF, which are
both down-regulated after NGN3 expression [2]. It is worth mentioning
that in the group of the TFBS in the WISP1 and CTGF orthologs, binding
sites for the AP4 factor were additionally found [2]. The current study re-
vealed the presence of this set of TFBS in the same orthologs for several
other genes, which according to the microarray data, are considered as
potential NGN3 targets. The names of the genes that were submitted for
regulatory region analyses in previous studies and in the current one as
well as details concerning their biological function are indexed in
Table 1. Remarkably, the presented in Table 1 genes are dissevered at
two distinct groups according to their up (+) or down (−) regulation
48 h after NGN3 induction. Fig. 1 depicts the relative positions of the
set of TFBS and its’ absolute distance from the transcription start site
Fig. 1. The regulatory complex of TFs belonging to the families NEUR, PDX1, BRNF, HNF1, HNF6, LEFF and AP4R, presented at the murine orthologs of the analyzed genes. The relative
positions of the TFBS are presented in scale and explained with the symbols at the right part of the picture. The presence of the AP4 factor in the down-regulated genes is indicated
with the black cross. The margins of the conserved regulatory region are marked with the vertical black lines. The distance of the TF cluster from the TSS (white bold arrow) is
counted with the ruler.
Table 2A
The number of the identiﬁedmoduleswith andwithout AP4 and the length in nucleotides
of the respective analyzed sequences.
Analysis Nucleotides Modules with AP4 Modules without AP4
Genome- wide 2.654.911.517 668 86.324
Selected genes 810.000 60 180
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bly, the bindingmotifs of 6 TFs belonging to the families: NEUR (NGN1/
3- NeuroGeNin1/3), HNF1 (HNF1A-Hepatocyte Nuclear Factor 1), HNF6
(HNF6-Hepatocyte Nuclear Factor 6) (ONECUT1- ONE CUT homeobox
1), BRNF (BRN2/5 (POU3F2/POU6F1)- BRaiN-speciﬁc homeobox/POU
domain proteins2/5 (POU class 3 homeobox 2/ POU class 6 homeobox
1)), PDX1 (PDX1-Pancreatic and Duodenal homeoboX 1 and ISL1-ISL
LIM homeobox 1) and LEFF (LEF1- Lymphoid Enhancer-binding Factor
1) were found co localized in a narrow genomic region. Conjointly,
AP4 factor (of AP4R family) was present only in the assembly of TFs in
the orthologs of the down-regulated genes of Table 1. Despite the alter-
native order of the previously referred TFBS into this region and their
variable distances from the TSS, their presence appeared to be con-
served in all the orthologs checked for every gene included in Table 1.
In the Table S3 of the SupplementaryMaterial 3, the positions of the dis-
covered cluster of TFBS relative to the TSS in the orthologs of all the an-
alyzed genes are listed. Obviously, these TFs stand for a highly
conserved regulatory module identiﬁed in all the orthologs, of species
with pancreas, for several genes possibly implicated into the endocrine
pancreas speciﬁcation process.
2.2. Whole genome analyses
Every single nucleotide of the murine genome was analyzed with a
code (Data and methods) developed in order to detect putative TFBS
for the TFs of the families NEUR, PDX1, HNF1, HNF6, BRNF, LEFF and
AP4R. In the sequel, the TFBS found in each chromosomewere searched
for clusters of TFBS for the factors belonging to the previously men-
tioned families. More precisely, two versions of another code scanned
for TFBS of the under study TFs that were co-localized in genomic re-
gions ofmaximum length 1000 bp (Data andmethods) in everymurine
chromosome.Moreover, the usage of the two alternative versions of the
second code, allowed the exploration of the presence of AP4 into each
cluster of TFBS. Indeed, the modules containing the factors NGN3,
PDX1, HNF1, HNF6, BRN4 and LEF1 were designated as clusters withoutAP4, whereas those containing the previously referred factors together
with AP4 were characterized as clusters with AP4.
The number of the clusters of TFs with and without AP4 that were
identiﬁed at the M. musculus genome, together with the length of the
whole genome's sequences in nucleotides is summarized in Table 2A.
In the same Table 2A these numbers are compared with the respec-
tive ones concerning the selected analyzed genes, from the microar-
ray data. It is worth pointing out that the modules containing AP4,
in contrast to those without AP4, were rare. Indicatively, along the
chromosome 11, which is the most gene rich chromosome of
mouse, only 18 modules with AP4 were found. In Fig. S4, of the Sup-
plementary Material 4, the modules residing inside the regions of
known genes are indicated with bold arrows and the corresponding
genes are labelled accordingly. On the other hand, the muchmore fre-
quent sets of TFBS lacking AP4 along the same chromosome, were
classiﬁed according to the annotation of the genomic region that
they were located and the results are presented in the pie chart of
the Fig. S5A of the Supplementary Material 5. Strikingly, according
to the pie chart of Fig. S5A, the modules without AP4 are mapped in
their majority at distal intergenic regions, while those with AP4
(Fig. S5B) are mostly located inside introns.
2.3. Statistical analysis
In order to ensure the statistical signiﬁcance of the identiﬁcation of
the two variants of the regulatory module, Table 2A's results were
subjected to statistical analysis. More speciﬁcally, linear correlation
Table 2B
Linear correlation of the number of modules with and without AP4 and the number of
the nucleotides of the analyzed sequences.
Dependent–independent
variable
Prediction
formula
P-value Adjusted R
square
Modules with
AP4-nucleotides (N)
ΑP4=2.556 e−7*Ν 0.0001 0.893
Modules without
AP4-nucleotides (N)
NOAP4=3.290 e−5*Ν 0.0001 0.968
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sequences, in nucleotides, with the number of the clusters of TFs
found within them. The analysis resulted into the predictive models,
shown in Table 2B, together with the respective p-values and the ad-
justed R squares. The equations of Table 2B estimated the number of
the clusters of TFs with and without AP4 (Dependent Variable) that
was expected to be found in a sequence consisting of a speciﬁc num-
ber of nucleotides (N- Independent Variable). The relatively low
values (2.556 e−7 and 3.290 e−5) of the linear correlation rates indi-
cated that the clusters of the selected TFs were not expectedmore fre-
quently, when the analyzed sequences were longer. Calculating the
number of the regulatory modules, through the equations of
Table 2B, that were expected to be found by chance and comparing
them with those occurred by the analyses of the selected genes, re-
vealed that both forms of the module, with and without AP4, were
foundmore frequently in the putative targets of NGN3, than occasion-
ally expected. Conﬁrming that, the identiﬁcation of these two distinct
modules was far from random. Likely, the existence of these alterna-
tive clusters of TFs in the sequences of the selected genes is linked
with their regulation by these TFs during the pancreas endocrine
cells’ subtypes’ differentiation.
2.4. Investigation of protein–protein interactions through data mining
from graphs
By performing Ingenuity Pathway Analysis (IPA) (Data and
methods) the up-to-date documented knowledge concerning the
protein–protein interactions among the TFs of the regulatory modules
was extracted. Speciﬁcally, setting the murine protein identities as
queries, all the experimentally identiﬁed alternative or combinatorial
trans-trans interactions were investigated, generating the suppositional
bundle of TFs shown in Fig. 2, which also provides information about
any possible activation of the interacting partners. The nodes of Fig. 2
stand for the proteins named inside them, while the lines indicate the
relationships explained in the right part of the ﬁgure. Sharply, as Fig. 2
illustrates, NGN3 can directly interact with CREB Binding Protein
(CREBBP) and with HNF1, which also interacts with CREBBP as well asFig. 2. The putative complex of the TFs foundwith Β-CaΤeΝiΝ (CTNNB1) [4–7]. CREBBP could also be characterized
as a cross linker of the protein complex shown in Fig. 2 as it additionally
interacts with the factor HNF6 [8]. Moreover, LEF1 binds Histone
DeACetylase 1 (HDAC1), which further interacts with AP4 and PDX1
[9–11]. Presumably, these factors can form alternative protein com-
plexes of the same regulatory module.
2.5. Structural study of protein–protein interactions
Among the factors of the putative regulatory protein complex of
Fig. 2, LEF1 and CTNNB1 were considered of major importance and
their interactions with other proteins were studied thoroughly. The no-
tability of LEF1 was arisen by the fact that LEF1 is present in the variants
of the regulatory module found in both the up and the down-regulated
genes. Moreover, LEF1 interacts with either HDAC1 and/or CTNNB1 by
suppressing or inducing the transcription of its targets respectively [9].
On the other hand, CTNNB1 is a general TF, whose transfer into the nu-
cleus and its’ interplaywith LEF1 is controlled by the canonicalWNT sig-
naling pathway [12]. In detail, when this pathway is active the
proteasome degradation of the cytosolic CTNNB1 is blocked, so that
CTNNB1 is available to be transferred into the nucleus, where it binds
CREBBP [12]. CREBBP is another general TF, acting at the same time as
a histone acetyltransferase that plays crucial role in embryonic develop-
ment via working as a transactivator of several TFs and as a regulator of
chromatin acetylation state [12]. As shown in Fig. 2, CTNNB1 binds LEF1,
while both of them can interact with HDAC1 [9]. In order to explore the
interactions among alternative partners and examine the putative ter-
nary complexes of these proteins,molecular docking of the solved struc-
tures or of the reliable models of these factors was performed using the
ZDOCK program (Data and methods). The complexes of the CTNNB1
with either the histone acetyltransferase CREBBP or with the histone
deacetylase HDAC1 are depicted in Figs. 3A and C respectively, validat-
ing previously published [9,12] interactions. When CTNNB1 is trans-
ferred into the nucleus, it facilitates the formation of the complex
CREBBP/CTNNB1/LEF1 shown in Fig. 3B, a tripartite complex pre-
sumed by [9], which was thermodynamically conﬁrmed by the here-
in presented in silico study. More precisely, in Figs. 3A, B and C the
structural representations of the ZDOCK docking results (colored red)
for the complexes of CTNNB1/CREBBP, CTNNB1/CREBBP/LEF1 and
CTNNB1/HDAC1 respectively, are shown superimposed with the re-
spective outputs of the 50 ns molecular dynamics (MD) simulations
(coloured green). In order to quantify the conformational changes for
themolecular complexes upon theMD simulations, each onewas com-
pared with its corresponding docking conformation, prior to MD simu-
lations, by calculating the root mean square deviations (RMSd)
between equivalent atoms. Noteworthy that large RMSd values are in-
dicative ofmajor conformational changes. However the CαRMSd values
for the complexes shown in Figs. 3A, B and C after the MD simulationswithin the conserved regulatory region.
Fig. 3. A. Superimposition of the CTNNB1/CREBBP complex as occurred by the ZDOCK
docking result (red colour), with the respective output of the 50 ns molecular dynam-
ics simulations (green color). B. Superimposition of the ZDOCK output for the complex
CTNNB1/CREBBP/LEF1 (red color) with the respective complex that occurred after the
50 ns molecular dynamics simulations (green colour). C. The ZDOCK output for the
complex CTNNB1/HDAC1 superimposed with the respective one obtained after the
50 ns molecular dynamics simulations.
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their equivalent docking structures. Therefore, with an average RMSd
of 0.33 Å (before/after MD), it was concluded for all three complexes
that their docking conformations remained stable throughout the ex-
haustive MD simulations. Upon the analysis of the full molecular dy-
namics simulations trajectory, depicted in Fig. 4, it was shown that
these three complexes quickly (after ~5 ns) reached equilibrium and
remained conformationally stable for the remaining simulation time
(~up to 50 ns). Consequently, these complexes are characterized by ex-
tremely low energy values, ensuring the reliability of the presented 3D
molecular systems.
2.6. Regulatory network construction
Using the IPA platform's applications a holistic regulatory network
was constructed that gave a putative explanation on how the previ-
ously described complex of TFs, could induce or suppress the expres-
sion of the analyzed genes in order to differentiate embryonicpancreas progenitors into the β cell subtypes. More speciﬁcally, the
selected genes form the microarray results were clustered as up or
down-regulated ones according to their fold change expression
values calculated 12, 24 and 48 h after NGN3 induction. Subsequent-
ly, the fold change values, corresponding to the three time points, and
the genes’ identities, were submitted separately for the up-regulated
and the down-regulated genes as distinct input datasets. Further-
more, a supplementary analysis was conducted for the fold change
values, of both the up-regulated and the down-regulated genes,
counted 48 h after NGN3 induction, All possible regulatory events
containing the genes under question, the NGN3 and the fewest num-
ber of eligible molecules were algorithmically computed and were in-
corporated into different genomic circuits. These circuits were,
consequently, integrated into a combinative network by including
as much information as possible and lacking any redundant regulato-
ry relationships. The ﬁnal network, illustrated in Fig. 5, veriﬁed the in-
duction of NGN3 known targets, NEUROD1 and NKX2-2, as well as the
induction of NGN1. Furthermore it was shown that NGN3 together
with HNF1 are necessary for the expression of PAX4 [4,13]. The pro-
teins NGN3 and NKX2-2 are major participants of the differentiation
process of pancreas progenitors into insulin producing cells through
inducing the expression of insulin gene (Insulin) [14]. In addition,
NEUROD1 controls the expression of ΙΑ, the protein of which in syner-
gy with NEUROD1 and PDX1 up-regulate the expression of NGN3
[15]. At the same time, NEUROD1 increases the expression levels of
PAX4, DCX and NKX2-2 [13,16]. The factor NKX2-2 binds and regulates
the expression of PAX4 and further increases the activation levels of
NGΝ1 and NGΝ2 proteins [14,17]. The latter one (NGN2) is crucial
for the transcription of NKX2-2 as well as for the expression and acti-
vation of DCX [16,18,19]. Details on the intermediate molecules, like
APP, associated with this network are presented in Table 3. APP is re-
sponsible for the up-regulation of HUD, which is another analyzed
gene [20]. Moreover, upon the insulin's presence in the cells, APP pro-
tein is gathered [21] and contributes to the activation of the previous-
ly described complex of TFs, mainly through the regulation of the
amount of β-catenin (CTNNB1) that is translocated into the nucleus
and is available to be bound into the protein cluster of Fig. 2 [22].
The quantity of CTNNB1, that enters the nucleus, is also regulated
by WNT5A [12]. When WNT5Α is expressed, it leads the cells to insu-
lin production [23] and increases the activation levels of CDC42 [24].
Additionally, WNT5Α protein participates into the non-canonical
WNT signaling pathway inhibiting the proteolysis of CTNNB1 by the
canonical WNT signaling pathway and at the same time increases
the concentration of Ca+2 inside the cells [12]. This last event has
been linked with the capability of the cells to produce insulin [25].
The concentration of Ca+2 is also regulated by the protein encoded
by FZD2, which interacts with WNT5 and must be suppressed, when
Ca+2 concentration has to be kept in high levels [12]. It is noteworthy
that the FZD2 down-regulation is in accordance with the VCL sup-
pression, as these two proteins usually form a protein complex [26].
It is also worth pointing out that the inactivation of VCL has been cor-
related with the capability of the cells to express insulin, while the
suppression of the VCL gene is affected by the retinoic acid, used at
the experimental differentiation protocol of insulin producing cells
[1,27]. As shown in Fig. 5, retinoic acid also induces CDC42, [28] the
protein of which activates and enforces insulin secretion [29]. More-
over, through the activation of MAPK8, CDC42 leads to the acute sup-
pression of the TNF factor [30,31]. So when CDC42 is present, TNF is
unable to induce its’ targets VCL, CTGF and WISP1, which are subse-
quently suppressed [32–34]. Recurring to CDC42 protein, it can be
characterized as a key molecule in the presented regulatory network,
as it directly induces the expression of PARD3 and through intermedi-
ate molecules upregulates ALDH1B1. The increased activation of
CDC42, as Fig. 5 illustrates, can be attributed to the induction of
FGD4, the protein of which interacts with CDC42 and activates it, as
well as the ΜΑPK8 protein [35]. Additionally, the activation of the
Fig. 4. Molecular dynamics simulations trajectory for the complexes of Figs. 3A, B and C. Graphical representation of the energy values for the complexes of CTNNB1 with CREBBP
and LEF1 (red line), CTNNB1 with CREBBP (green line) and CTNNB1 with HDAC1 (blue line).
217M. Kapasa et al. / Genomics 100 (2012) 212–221NFKB complexes is a situation linked with insulin secreting cells [36],
depends on CDC42 and is increased by F2 [37]. Finally, the activated
NFKB complexes, under the guidance of F2, up-regulate ΑLDH1B1 [38].
However, the presence of AP4 in the regulatory module of the
down-regulated genes (i.e. in PARD6B) activates TP53, which then sup-
presses the respective gene [39,40]. On the other hand, the activation
of TP53 up-regulates the expression of LIF protein, leading into theFig. 5. Regulatory network guided by NGN3, indicating the interactions among the TFs of th
teractions, the up or down-regulation of the analyzed genes and the intermediate moleculeup-regulation of RGS4 [41,42]. Lastly, this network shows that LEF1 in-
duces ΒRN2 transcription, the protein of which dimerizes with BRN4
[43,44]. The latter (BRN4) guides the cells’ glucagon production, which
coexistswith the insulin secretion at the primary states of differentiation
of embryonic pancreas progenitors [1,2].
In conclusion, through the proper transcriptional regulation of the
analyzed genes by the presented variants of the regulatory module,e conserved regulatory module and the analyzed genes. The types of the presented in-
s of the network are described with the symbols at the right part of the picture.
Table 3
Information concerning the intermediate participants of the regulatory network shown
in Fig. 5.
Acronym Molecule Biological Function
NGN2 NeuroGeniN 2 Transcription regulator. Neural system
development.
NGN1 NeuroGeniN 1 Transcription regulator. Neural system
development.
APP Amyloid beta (A4)
precursor protein
Cell surface receptor. Precursor of a
transmembrane protein. After proteolysis turns
into small peptides that induce transcription.
Neural system development.
BRN2 (POU3F2) POU class
3 homeobox 2
Transcription regulator. Neural system
development
NFKB Nuclear factor kappa
B
Protein complex. Regulation of transcription and
apoptosis.
TP53 Tumor protein p53 Oncogene product. Control of cell cycle,
apoptosis, DNA damage repair, cell aging and
metabolism. DNA binding and induction of
transcription. Regulation of neural system
growth.
F2 Coagulation factor II
(thrombin)
Factor that after proteolysis becomes thrombin.
Regulation of blood coagulation and circulation
in neonates and embryos. Growth factor.
Proteolysis of other proteins. Regulation of
neural cell differentiation.
LIF Leukaemia
inhibitory factor
Cytokine. Neural cell differentiation and
organogenesis of multicellular organisms.
TNF Tumor necrosis
factor
Cell cycle regulator. Regulation of cell
proliferation, differentiation and apoptosis.
MAPK8 Μitogen-activated
protein kinase 8
Phosphorylation of speciﬁc protein-targets
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producing ones can be achieved.3. Discussion
Through the regulatory region analyses of genes known and puta-
tive targets of NGN3 [1,4] a genomic region, where particular TFs bind
was identiﬁed. These factors belong to the TF families NEUR, PDX1,
HNF1, HNF6, BRNF, LEFF and AP4R. Subsequently, it can be assumed
that NGN3 (of NEUR family); the main regulator of endocrine pancreas
cell subtypes’ speciﬁcation [1], in association with the rest TFs of the
cluster, constitute two variants of a regulatory module, which rules ei-
ther the induction, or the suppression of the respective gene's transcrip-
tion. Speciﬁcally, the group of the TFBS belonging to the 6 ﬁrst TF
families was found in both the up and down-regulated genes upon
NGN3 induction, but only the modules of the down-regulated genes
contained the factor AP4 of the last family. Consequently, it could be hy-
pothesized that AP4 selectively binds at the cluster of the TFs NGN3-
PDX1-HNF1-HNF6-BRN4-LEF1 and converts this regulatory region
into a silencer.
It is worth mentioning that the AP4 factor has been documented to
bind into an enhancer element of the genes speciﬁcally expressed in
pancreas [45,46]. Likewise, all the other factors of this cluster are
known to participate in the embryonic development of pancreas. Pre-
cisely, PDX1 and ISL1 regulate insulin gene expression and guide islet
cell development, whileHNF6 andHNF1 are both transcriptional activa-
tors of pancreas-speciﬁc genes [2]. Furthermore, the factors BRN2,
BRN3, BRN4, and BRN5, classiﬁed into the BRNF family, are known reg-
ulators of gene expression that rules the mammalian embryonic devel-
opment. Among the BRNFmembers, BRN4must be primarily concerned
with the activation of the glucagon gene [2]. Additionally, the only rep-
resentative of the LEFF TF family, LEF1, participates into the canonical
WNT signaling pathway, which is implicated into the pancreas organo-
genesis [12].Yet, through the statistical analysis of the results occurring from
the whole mouse genome analyses it was proven that the two types
of clusters of TFBS, with and without AP4, were not randomly identi-
ﬁed inside the regulatory regions of the selected analyzed genes.
Conjointly, the fact that this region was found conserved for every
gene analyzed, even at the most phylogenetically distant species that
have pancreas, indicates its’ functionality in the regulation of expres-
sion of the analyzed genes during the morphogenesis of pancreas. In-
deed, functional regulatory elements are usually highly conserved
genomic regions, as the selective pressure acts on them and retains
through evolution the binding motifs of the TFs with major impor-
tance for the regulation of the respective gene. Noticing that this re-
gion was identiﬁed far beyond the TSS for most of the analyzed
genes (Supplementary Material 3, Table S3), it is estimated that, it
acts as a distant regulatory element. Strikingly, the selective presence
of the AP4 factor only in the group of TFs that was identiﬁed in the
down-regulated genes, makes AP4 a focal molecule that inverts the
modules’ functionality from an enhancer into a silencer one.
Besides, the plausible protein bundle of Fig. 2, that transpired
though the integration of all known protein–protein interactions, sig-
niﬁes that the TFs bound into the conserved genomic region, interact
also with HDAC1, CREBBP and CTNNB1, synchronously or not in var-
ious combinations. It seems that the factors NGN3, PDX1, HNF1,
HNF6, BRN4, AP4 and LEF1 stand for the core of different clusters
that contain either the histone deacetylase HDAC1 or the histone
acetylase CREBBP. Hence, the resulting alternative protein complexes
suppress or induce the transcription of the corresponding genes re-
spectively. Additionally, the mediator's CTNNB1 and the HDAC1's
presence into these complexes are controlled by LEF1, while AP4
also recruits HDAC1 into the module.
In detail, combining the information provided in Figs. 2, 3A and C
it can be assumed that the putative regulatory module is consisted of
the general TF CTNNB1, which can interact with both the CREBBP and
the HDAC1. These results are in accordance with previous studies
showing that when CTNNB1 is bound to LEF1 it induces the transcrip-
tion of LEF1 dependent genes and disturbs the binding of LEF1 to
HDAC1 [9]. Concerning HDAC1 it seems that it combines various
roles beyond working as a histone deacetylase, as it also acts as a
crosslinker of the factors PDX1 and AP4 with the rest TFs of the com-
plex of Fig. 2 [10,11]. In conclusion, these ﬁndings conﬁrm the indica-
tions that HDAC1 decreases the ability of LEF1 to function as a
transcriptional activator [9]. Moreover, Fig. 3B depicts the complex
of CTNNB1 with LEF1 and CREBBP, supporting the hypothesis [9]
that an acytyltranferase is also present in the complex of CTNNB1
with LEF1. Therefore, it could be presumed that with this trans regu-
latory elements combination, a looser chromatin state is achieved via
increasing the local chromatin acetylation levels; a situation generally
linked with the induction of transcription. Based on the fact that AP4
was found only into the suppressed genes, it could be characterized as
a co-repressor, attracting the deacetylase HDAC1 into the protein
complex and leading into more compact chromatin structures and ﬁ-
nally into the transcriptional repression of the genes. The latter con-
clusion conﬁrms the assumption that an unknown co-repressor is
also present in the complex of LEF1 with HDAC1 [9].
Through the induction or the suppression of the analyzed genes the
embryonic pancreas progenitors were differentiated towards the direc-
tion of insulin producing cells. Indeed, focusing on the regulatory net-
work of Fig. 5 it is worth noting that the down-regulation of BHLHB2,
known to be retinoic acid dependent, is of major importance for the dif-
ferentiation of pancreatic cells. In detail, BHLHB2 is expressed at the ini-
tial phases of differentiation of the endocrine pancreas progenitors,
after treatment with the retinoic acid [47]. Additionally, the transcrip-
tional regulation of CTGF is crucial for the formation of the pancreatic is-
lets and for the determination of the endocrine pancreas cell subtypes
in the right proportion. Indeed, CTGF is keenly expressed at the epithe-
lium of the pancreatic buds and its’ expression falls at lower levels
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tally suppressed after birth in the already differentiated β-cells of pan-
creas. It seems that CTGF controls the β cells’ subtypes’ proliferation
during their differentiation process, as in knock-out, for this gene, ex-
perimental models, lower than normal proliferation rates of the cells
have been documented [48]. On the other hand, concerning the
up-regulated genes analyzed here, unpublished data indicated their im-
plication into pancreas morphogenesis and in β cells’ differentiation. In
detail, increased expression of ALDH1B1 has been found during the dif-
ferentiation protocol of pancreas progenitorswith selective induction of
NGN3, aswell as in the developing early pancreatic buds ofmice embry-
os. The expression of ALDH1B1 depends on PDX1 and has been marked
in progenitor cell populations of both the endocrine and the exocrine
pancreas [manuscript under preparation]. Even more, CDC42 has been
proved to determine the cell fate of embryonic stem cells in the early
embryo, via controlling the suitable and sufﬁcient microenvironment
for the proper differentiation of pancreas progenitors. Moreover,
CDC42 ensures the pancreas tubulogenesis initially through the creation
of microlumen and then through the maintenance of the apical cell po-
larity [49]. Additionally, RGS4 has recently been proved to be regulated
by NGN3 in endocrine progenitor cells of zebraﬁsh (Danio rerio) and
mice, as well as in pancreatic epithelial cells of murine embryos.
Concerning this, loss of RGS4 leads to the deregulation of endocrine
cell migration in early embryos of zebraﬁsh and mice, resulting into
the disturbance of the proper formation of pancreatic islets [50].
At the primary differentiation stages cells maintain their capability
to secrete both insulin and glucagon [1,2], but as the differentiation
process proceeds the insulin production predominates over glucagon
production. The genes that are controlled by the identiﬁed variants of
the regulatory module incite a set of intracellular changes, mainly
guided by NGN3, where the antagonism between the canonical and
non-canonical WNT signaling pathways is crucial. It is noteworthy
that, LEF1 is both the core factor of the alternative regulatory com-
plexes of TFs presented here and the main participant of the canonical
WNT signaling pathway.
Summarizing, LEF1 that was identiﬁed in the conserved regulatory
module of all the analyzed genes forms alternative complexes with
the previously mentioned TFs and through the antagonism of
CREBBP with HDAC1 the local acetylation levels of the chromatin
abet or prevent transcription. The selective suppression of transcrip-
tion by the recruitment of HDAC1 into the protein cluster could be
possibly attributed to the AP4 factor. This factor by residing its’ bind-
ing motifs exclusively inside the regulatory regions of the suppressed
genes and by interacting with LEF1 and HDAC1, may assist the HDAC1
recruitment to the protein complex. Moreover, the 50 ns MD simula-
tions revealed that all three complexes presented in Figs. 3(A,B,C)
soon reached a conformational equilibrium, even though they en-
tered the MD simulations with variable starting energies (Fig. 4).
Taken together these observations illustrated the viability of the
docking results of the ZDOCK experiment for all three complexes. Fur-
thermore, the low RMSd values indicated that these complexes
remained conformationally close to their initial docking poses upon
the minimization and the MD simulation courses that followed,
reﬂecting the structural reliability of the adapted docking interaction
patterns.
Conclusively, the presented study revealed details concerning the
regulatory circuits that enable the pancreas progenitors to become in-
sulin producing cells. Promising TFBS, in genes with main participation
into this differentiation process, occurred, calling for experimental val-
idation. Furthermore, hypothetical protein complexes came into being
awaiting for biochemical afﬁrmation or molecular dynamics simulation
endorsementwhen the suitable crystal structures become available. Be-
sides, the genome-wide distribution of the two types of the discovered
regulatory module and the annotation of the respective residence re-
gions may unfold new perspectives and provide insights about these
regulatory elements.4. Data and methods
4.1. Regulatory region analyses of selected from microarray data genes
Gene expression proﬁling of embryonic pancreas progenitors, in
which NGN3 had been induced, indicated a number of genes whose ex-
pression increased or decreased 12–48 h after NGN3 induction. These
genes, known and putative targets of NGN3, were selected for regulato-
ry region analyses, aiming at the veriﬁcation of the experimentally iden-
tiﬁed binding sites of NGN3 in its’ known targets and at the revelation of
the predicted ones in the rest of the genes. In order to enforce the ro-
bustness of the method used, for each selected gene ten orthologs of
species that have pancreas were analyzed. Therewithal, the orthologs
from organisms, normally distributed across the phylogenetic distance
from mammals to ﬁshes were identiﬁed with the Reciprocal Best Blast
Hit method, using as reference sequences the respective murine pro-
teins, as extracted from Ensembl database (http://www.ensembl.org/
index.html). The genomic regions for each one of the analyzed genes,
extending 4500 bp upstream to 500 bp downstream of the TSS were
also obtained by Ensembl database (http://www.ensembl.org/index.
html) for the species shown in Supplementary Material 2, Fig. S2. The
retrieved regulatory sequences were submitted to the MatInspector
platform in Genomatix Database (http://www.genomatix.de/en/index.
html) in order to identify putative TFBS for all the TFs of Matrix Library
7.1. The TFBSwere primarily predicted setting as cut- off parameters the
core similarity score (css) at 0.75, and selecting the “optimized” matrix
similarity score (mss). In an effort to increase the results’ reliability,
only the TFBS common to all the orthologs for every gene checked
were accepted. Subsequently, the experimentally veriﬁed TFBS for
NGN3 in the genes known targets were considered as references and
their mss and css values were set as cut- off parameters for the reliable
identiﬁcation of the TFBS for the NEUR TF family (where NGN3 belongs).
Setting these sites as mandatory elements, a detailed search for regions
of maximum length 1000 bp, which also contained TFBS for additional
factors, was performed. Towards this direction and based at an addition-
al ﬁltering method applied in a previous work [2], clusters of phyloge-
netically conserved TFBS for factors belonging to the families NEUR,
PDX1, HNF1, HNF6, BRNF, LEFF and AP4R were identiﬁed.4.2. Whole genome analyses
Certain limitations of MatInspector, like the maximum number of
matches that can be printed to output, led to the implementation of an
in-house tool for the identiﬁcation of putative TFBS in all the DNA se-
quences of an entire genome. Therefore, a tool called “TFBS_Identiﬁer”
was built in C in order to perform the regulatory analyses of the whole
mouse genome sequences for the TF families of interest. The identiﬁca-
tion of putative TFBS was performed using available Position Weight
Matrices (PWMs) and computing css and mss, between the PWM and
the query sequence. More information about the algorithm can be
found at MatInspector Publications (http://www.genomatix.de/en/
index.html). “TFBS_Identiﬁer” was constructed to take as input the
query sequence, the PWM and a threshold for each of the css and mss.
The query sequences were those belonging to each of the 21 chro-
mosomes of the murine genome (INSDC Genome Collections Acces-
sion GCF_000001635.18) corresponding to coding and non‐coding
or intergenic regions that were extracted from the Ensembl Database
(ftp://ftp.ensembl.org/pub/current_fasta/mus_musculus/dna). The PWM
for the TF families NEUR, PDX1, HNF1, HNF6, BRNF, LEFF and AP4R
were retrieved from the MatBase Database of the Genomatix Suite
(http://www.genomatix.de/en/index.html). The cutoffs used for the css
and mss were identical with those used at the analyses of the selected
from microarray data genes. Speciﬁcally, for NEUR family the cutoff
value of mss was set at 0,92, as this value veriﬁed the experimentally
identiﬁed binding sites of NGN3.
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with another code named “Cluster_Detector”. This code, written in
C++ read the TFBS ﬁles and, setting binding sites of NEUR TF family
with mss greater than 0.92 as anchors, searched 500 bp both upstream
and downstream of these points for TFBS of the previously mentioned
TF families. Two alternative versions of “Cluster_Detector”were execut-
ed at Linux environment and lead into the identiﬁcation of clusters of
TFBS, representing the two variants of the module (with or without
the AP4 factor).
4.3. Statistical analysis
The Pearson correlationwas applied for the statistical analysis of the
two variants of themodule thatwere identiﬁed in the selected frommi-
croarray data genes as well as in the sequences comprising the mouse
genome, either ﬁtting genes or intergenic regions. The analysis was
performed with the SPSS 16.0 package considering a signiﬁcance level
at pb0.05. Indeed, linear correlation was used to describe the relation-
ship between the number of the two alternative types of the regulatory
module and the number of the nucleotides of the analyzed sequences. It
is noteworthy that, the total length of the analyzed genes’ sequenceswas
calculated by multiplying the number of the selected genes (Table 1)
with the number of the orthologs (10) checked for each one and with
4500 bp counting for each analyzed gene's sequence. It is alsoworth not-
ing that the orthologs of the previously analyzed genes B-ACTIN (ACTB)
and B-GLOBIN (HBB), which used as negative controls [3], were excluded
from this calculation. On the other hand, the information concerning the
length in nucleotides of the murine genome was provided by Ensembl
Database (http://www.ensembl.org/index.html).
4.4. Regulatory network construction
The putative complex of TFs and the regulatory network presented
in Figs. 2 and 5 respectively were constructed through the applications
of the Ingenuity Pathway Analysis (IPA) (http://www.ingenuity.com/).
More precisely, the regulatory bundle of Fig. 2 was constructed by re-
trieving the documented knowledge concerning the protein–protein
interactions among the TFs of the conserved regulatory module setting
as queries the protein identities and searching for a suppositional as-
semblage containing all of them. On the other hand, the fold changes
of expression of the analyzed genes, retrieved at 12, 24 and 48 h after
NGN3 induction [1] were set as disparate input datasets in the IPA Plat-
form and distinct analyseswere performed for the up-regulated and the
down-regulated genes. Moreover, a complementary analysis was also
performed, setting as query the expression fold changes of both the in-
duced and the suppressed genes, 48 h afterNGN3 induction. The results
of these analyses were combined into a ﬁnal network depicted in Fig. 5,
where all the regulatory events concerning the under question genes
were embedded into the presented bunch of edges and lines, while
the redundant ones were trimmed. For both approaches leading to
Figs. 2 and 5, up to 3 eligible molecules were allowed to intervene
among the query molecular players. It is noteworthy that, 3 intermedi-
atemolecules reﬂect a chance of 10−3 of the respective edge to have oc-
curred by chance.
4.5. Structural study of protein–protein interactions
The structural study of trans–trans interactions was performed after
retrieving the solved structures for the TFs of interest from Protein Data
Bank (PDB) (http://www.pdb.org/pdb/home/home.do). Additionally,
models through comparative modelling were constructed for the fac-
tors lacking solved structures, based at experimentally veriﬁed struc-
tures of proteins with which greater than 30% sequence similarity was
shared. Comparative modelling was conducted with SWISS MODEL
(http://swissmodel.expasy.org/) and the models were subsequently
evaluated with ANOLEA (http://protein.bio.puc.cl/cardex/servers/anolea/index.html). The experimentally identiﬁed structures and
the constructed models were used for molecular docking with
ZDOCK version 3.0, while RDOCK was utilized to minimize the
ZDOCK molecular complex outputs and rank them according to
their re-calculated binding free energies. Protein complexes were
further subjected to an extensive energy minimization run using
the Amber99 forceﬁeld as it was implemented into the Gromacs, ver-
sion 4.5.5, via a previously developed graphical interface for it. An
implicit Generalized Born (GB) solvation was chosen at this stage, in
an attempt to speed up the energyminimization process. In order to ex-
plore further the interaction space and binding potential of each
docking conformation, the molecular complexes were subjected to un-
restrained molecular dynamics simulations using the Gromacs suite,
version 4.5.5. Molecular dynamics took place in a periodic environment,
which was subsequently solvated with Simple Point Charge (SPC)
water using the truncated octahedron box, extending to 7 Å from
each molecule. Partial charges were applied and the molecular systems
were neutralized with counter-ions as required. The temperature was
set to 300 K, the pressure at 1 atm and the step size was set to 2 fs.
The total run of each molecular complex was ﬁfty nanoseconds
(50 ns), using the Number of atoms, the Volume and the Temperature
(NVT), that remain constant throughout the calculation, in a canonical
environment. The results of the MD simulations were collected into a
molecular trajectory database in order to be further analyzed. Principal
component analysis was done using Pymol (DeLano, W. L. The PyMoL
Molecular Graphics System (2002), http://www.pymol.org) and the
Ca atom root-mean-square function of Deep-View. Analyses of the MD
outputs and trajectorieswere therefore focused on structural deviations
of each molecular system from its original docking conformation. The
molecular systems were neither restrained nor constrained throughout
the simulation, with the exception of the DNA coordinates for the com-
plex shown in Fig. 3B, which were ﬁxed in the molecular dynamics pe-
riodic three dimensional space. The MD ﬁnal conformations were
initially evaluated with a residue packing quality function built-in the
Gromacs suite, depending on the number of buried non-polar side
chain groups and on hydrogen bonding. Moreover, the suites Procheck
and Verify3Dwere employed to evaluate the structural viability of each
protein complex upon the MD simulations. Illustrations of the molecu-
lar systems were rendered with the aid of the Chimera suite.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.ygeno.2012.07.002.
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